A leading pharmaceutical organization’s medical affairs team was purposed with acquiring this multi-touchpoint feedback around the subject of psoriasis. Specifically, the team needed to engage 2 sets of clinical experts – dermatologists and pharmacists. Faced with a corporate-mandated reduction in live advisory board funding, the team needed an alternative meeting option that would prove both cost-effective and logistically friendly. This additional engagement opportunity would need to facilitate discussions tailored to each group’s unique roles and perspectives around treatment options, patient perspectives, and required materials for optimal patient education.
This case study examines how the medical affairs team innovatively addressed their objectives.